摘要:
A superconducting magnet abnormality detection and protection apparatus is for early and surely detecting abnormality in superconducting coils mounted on a vehicle and protecting the superconducting coils. Magnetic flux detecting devices are mounted inside an outer vessel, which is a vacuum container of a superconducting magnet, so as to be opposite to the superconducting coil. Voltages induced in the magnetic flux detecting devices are detected. Voltage signals are led to a decision device. By monitoring the change of the voltage signals with time in a comparing judgment device, it is determined whether there is an abnormality. If there is an abnormality, an alarm indicator informs of an abnormal state, and a protection device takes protection measures such as interruption of the current of the superconducting magnet. Owing to such configuration, heat does not penetrate from the outside into the superconducting coil via instrumentation lead wires of the magnetic flux detecting devices. Magnitudes of vibration and displacement of the superconducting coil can be detected without contacting the superconducting coil. By always monitoring these signals, it becomes possible to early detect an abnormality in the superconducting coil and protect it.
摘要:
In a camera with a line of sight detecting device, the optical axes of an observation optical system, illuminating means and photoelectric converting means are disposed so as to differ from one another, whereby it never happens-that in the observation optical system, illuminating light creates ghost, and the calculation of the direction of line of sight can be accomplished effectively.
摘要:
The present invention relates to a thienoimidazopyridone derivative represented by Formula (I): ##STR1## wherein A and B independently represent --S-- or --CH.dbd., X-Y-Z represents --N(R.sup.2)--CH.dbd.N-- or --N.dbd.CH--N (R.sup.2)-- wherein R.sup.2 is hydrogen, lower alkyl or --CH(R.sup.3)--(CH.sub.2).sub.n --R.sup.4 wherein R.sup.4 is phenyl, n is 0 or 1, and R.sup.3 is hydrogen or lower alkyl, and R.sup.1 represents lower alkyl, or a pharmaceutically acceptable salt thereof.
摘要:
A xanthine derivative of the formula (I): ##STR1## wherein R.sup.1 represents substituted or unsubstituted lower alkyl, lower alkenyl, lower alkynyl, substituted or unsubstituted alicyclic alkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted benzyl;R.sup.2 represents --(CH.sub.2).sub.m --X, wherein m is 2 or 3, and X is ##STR2## wherein a is NH, O or S, b and d are the same or different and are CH or N, and R.sup.3 is lower alkyl, substituted or unsubstituted alicyclic alkyl, or substituted or unsubstituted phenyl, or ##STR3## wherein e, g and h are the same or different and are CH or N, and R.sup.3 is the same as defined above;Q represents substituted or unsubstituted alicyclic alkyl, ##STR4## wherein R.sup.4 and R.sup.5 are the same or different and are substituted or unsubstituted alicyclic alkyl, ##STR5## wherein Y is single bond or alkylene; and n is 0 or 1, ##STR6## wherein K-M is --CH.sub.2 --CH.sub.2 --or --CH.dbd.CH--, and Y is the same as defined above, or ##STR7## wherein Y is the same as defined above; or a pharmacologically acceptable salt thereof is disclosed.This derivative has anti-dementia activity.
摘要:
Quinoline derivatives represented by formula (I): ##STR1## wherein A-B-D represents --C(COO--Y).dbd.CH--C(OR).dbd. (wherein Y represents 8-methyl-8-azabicyclo[3.2.1]oct-3-yl group and R represents alkyl) or --C(OH).dbd.C(COX--Y)--CH.dbd. (wherein X represents --O-- or --NH--; and Y has the same meaning as described above), or a pharmaceutically acceptable salt thereof, possess potent 5HT.sub.3 antagonizing activity and are useful as antiemetic agents.
摘要:
A lens for an underwater camera is comprised of a first lens unit having no refractive power or having weak refractive power, a second lens unit comprising a forward unit having negative refractive power and a rearward unit having positive refractive power, and having weak refractive power, a third lens unit having positive refractive power, and a fourth lens unit having negative refractive power, the first lens unit being fixed relative to the image plane, the second lens unit and the third lens unit being axially moved together on the optical axis toward the object side relative to the fourth lens unit.
摘要:
There are disclosed s-triazolo[3,4-i]purine derivatives represented by formula: ##STR1## wherein Y-Z represents ##STR2## R.sub.4 represents hydrogen, alkyl, substituted or unsubstituted aromatic heterocyclic group or substituted or unsubstituted aryl; and X.sup.2 represents oxygen, sulfur or NH; each of R.sup.1 and R.sup.2 independently represents hydrogen, alkyl, cycloalkyl, aralkyl or substituted or unsubstituted aryl; R.sup.3 represents alkyl, cycloalkyl, aralkyl or substituted or unsubstituted aryl; X.sup.1 represents oxygen or sulfur; and represents a single bond or a double bond or pharmaceutically acceptable salts thereof.
摘要翻译:公开了由下式表示的三唑并[3,4-i]嘌呤衍生物:其中Y-Z表示R 4表示氢,烷基,取代或未取代的芳族杂环基或取代或未取代的芳基; X2表示氧,硫或NH; R 1和R 2各自独立地表示氢,烷基,环烷基,芳烷基或取代或未取代的芳基; R3表示烷基,环烷基,芳烷基或取代或未取代的芳基; X1表示氧或硫; 并且表示单键或双键或其药学上可接受的盐。
摘要:
Disclosed is a thienopyridine derivative represented by formula (I): ##STR1## wherein one of A and B represents --S-- and the other represents --CH.dbd.; X represents --O-- or --NH--; R.sup.1 represents hydrogen or lower alkyl; R.sup.2 represents lower alkyl; and n represents 0 or 1; or a pharmaceutically acceptable salt thereof.The thienopyridine derivative is useful as anti-emetics and suppressant of migraine.
摘要:
The present invention discloses a manufacturing method for polarization maintaining optical fiber couplers which are used for joining light signals and at optical fiber branch points. The disclosed manufacturing method employs polarization maintaining optical fibers, and describes a method for mutually aligning the stress applying parts of such optical fibers so that polarized optical signals are maintained in the polarized state when transiting such couplers.
摘要:
Novel imidazoquinolone derivative represented by formula (I); ##STR1## wherein R.sup.1 represents lower alkyl or --(CH.sub.2).sub.m CO--R.sup.3 where R.sup.3 represents hydrogen, lower alkyl, hydroxy or lower alkoxy; and m is an integer of 1 to 3; R.sup.2 represents lower alkyl; or a pharmaceutically acceptable salt thereof.